Abstract
Monoclonal antibody (mAb) MN423 recognizes Alzheimers disease specific conformation of tau protein assembled into paired helical filaments (PHF). Since the three-dimensional structure of PHF is currently unavailable, the structure of MN423 binding site could provide important information about PHF conformation with the consequences for the Alzheimers disease prevention and cure. Fab fragment of MN423 was prepared and purified. We have identified two different conditions for crystallization of the Fab fragment that yielded two crystal forms. They diffracted to 3.0 and 1.6 Å resolution with four and one molecule in the asymmetric unit, respectively. Both crystal forms belonged to the space group P21 with unit cell parameters a = 76.4 Å, b = 138.4 Å, c = 92.4 Å, β = 101.9∞, and a = 71.5 Å, b = 36.8 Å, c = 85.5 Å , β = 113.9∞.
Keywords: Alzheimer's disease, Paired Helical Filaments, Fab fragment, Crystallization, X-ray data
Protein & Peptide Letters
Title: Preparation, Crystallization and Preliminary X-Ray Analysis of the Fab Fragment of Monoclonal Antibody MN423, Revealing the Structural Aspects of Alzheimers Paired Helical Filaments
Volume: 13 Issue: 9
Author(s): Natalia Csokova, Rostislav Skrabana, L'ubica Urbanikova, Branislav Kovacech, Alexander Popov, Jozef Sevcik and Michal Novak
Affiliation:
Keywords: Alzheimer's disease, Paired Helical Filaments, Fab fragment, Crystallization, X-ray data
Abstract: Monoclonal antibody (mAb) MN423 recognizes Alzheimers disease specific conformation of tau protein assembled into paired helical filaments (PHF). Since the three-dimensional structure of PHF is currently unavailable, the structure of MN423 binding site could provide important information about PHF conformation with the consequences for the Alzheimers disease prevention and cure. Fab fragment of MN423 was prepared and purified. We have identified two different conditions for crystallization of the Fab fragment that yielded two crystal forms. They diffracted to 3.0 and 1.6 Å resolution with four and one molecule in the asymmetric unit, respectively. Both crystal forms belonged to the space group P21 with unit cell parameters a = 76.4 Å, b = 138.4 Å, c = 92.4 Å, β = 101.9∞, and a = 71.5 Å, b = 36.8 Å, c = 85.5 Å , β = 113.9∞.
Export Options
About this article
Cite this article as:
Csokova Natalia, Skrabana Rostislav, Urbanikova L'ubica, Kovacech Branislav, Popov Alexander, Sevcik Jozef and Novak Michal, Preparation, Crystallization and Preliminary X-Ray Analysis of the Fab Fragment of Monoclonal Antibody MN423, Revealing the Structural Aspects of Alzheimers Paired Helical Filaments, Protein & Peptide Letters 2006; 13 (9) . https://dx.doi.org/10.2174/092986606778256180
DOI https://dx.doi.org/10.2174/092986606778256180 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protective Effect of Schizolobium parahyba Flavonoids Against Snake Venoms and Isolated Toxins
Current Topics in Medicinal Chemistry Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai
Current Alzheimer Research Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models
Current Cancer Drug Targets Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
Current Alzheimer Research Modulation of TNF Receptor Family Members to Inhibit Autoimmune Disease
Current Drug Targets - Inflammation & Allergy Meet Our Editorial Board Member
Current Neuropharmacology Subject Index To Volume 7
Current Pharmaceutical Biotechnology Commentary Research Highlights (Amyloid and Alzheimer's Disease: Easing the Load)
CNS & Neurological Disorders - Drug Targets Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods
Current Protein & Peptide Science Effective Biomarkers for Proof-of-Concept
Current Medical Imaging Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets Stimulus-feature Specific Modulation of the Visual Processing by Audiovisual Intermodal Orientation of Attention
Neuroscience and Biomedical Engineering (Discontinued) Synthesis and Anticonvulsant Activity of Some Cinnamylpiperazine Derivatives
Letters in Drug Design & Discovery The Effect of Casein Kinase 2 Inhibition on three Leukemic Cell Lines
Current Drug Therapy Immunomodulatory Actions of Vitamin D Metabolites and their Potential Relevance to Human Lung Disease
Current Respiratory Medicine Reviews Editorial
Current Drug Safety Astrocytes Exert and Control Immune Responses in the Brain
Current Immunology Reviews (Discontinued) Triterpenoids for Cancer Prevention and Treatment: Current Status and Future Prospects
Current Pharmaceutical Biotechnology Pharmacogenetics of Obesity Drug Therapy
Current Molecular Medicine Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets